PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

NCT03655236 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

513

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated based on study outcomes

Conditions

Early Parkinson Disease

Interventions

DRUG: K0706
DRUG: K0706
OTHER: placebo

Sponsor

Sun Pharma Advanced Research Company Limited